The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of raltitrexed combinations with uracil-tegafur or Mitomycin C as salvage treatment in advanced colorectal cancer patients.
Metin Ozkan
No relevant relationships to disclose
Oktay Bozkurt
No relevant relationships to disclose
Halit Karaca
No relevant relationships to disclose
Ersin Ozaslan
No relevant relationships to disclose
Osman Onur Daloglu
No relevant relationships to disclose
Aydin Ciltas
No relevant relationships to disclose
Mehmet Ali Kaplan
No relevant relationships to disclose
Mustafa Benekli
No relevant relationships to disclose
Alper Sevinc
No relevant relationships to disclose
Umut Demirci
No relevant relationships to disclose
Tulay Eren
No relevant relationships to disclose
Hilmi Kodaz
No relevant relationships to disclose
Abdurrahman Isikdogan
No relevant relationships to disclose
Suleyman Buyukberber
No relevant relationships to disclose